Differentiation fates of human mesenchymal stem cells in immunocompromised mice

Differentiation fates of human mesenchymal stem cells in immunocompromised mice

Bibliografski detalji
Glavni autori:	Xia, Z, Lockli, R, Triffitt, J
Format:	Journal article
Izdano:	2008

Slični predmeti

Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
od: Xia, Z, i dr.
Izdano: (2008)

Innate immune responses to human mesenchymal stem cell implantation in immunocompromised mice
od: Xia, Z, i dr.
Izdano: (2004)

Innate immune response to human mesenchymal stem cell implantation in immunocompromised mice
od: Xia, Z, i dr.
Izdano: (2004)

Differentiation of human mesenchymal stem cells at specific tissue sites in immunodeficient mice.
od: Xia, Z, i dr.
Izdano: (2003)

Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
od: Shoichiro Kokabu, i dr.
Izdano: (2016-01-01)

Tissue responses to mesenchymal stem cells and biomaterial implants
od: Xia, Z, i dr.
Izdano: (2007)

The Life and Fate of Mesenchymal Stem Cells
od: Elke eEggenhofer, i dr.
Izdano: (2014-05-01)

Genetic labelling of human bone marrow osteogenic stem cells: Differentiation potentials and engraftment into NOD/SCID mice.
od: Xia, Z, i dr.
Izdano: (2001)

Scaffold characterisation for human mesenchymal stem cell culturing
od: Trainor, N, i dr.
Izdano: (2007)

Human mesenchymal stem cell numbers do not decrease with age
od: Oreffo, R, i dr.
Izdano: (1996)

Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice.
od: Xia, Z, i dr.
Izdano: (2004)

Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
od: Na Wang, i dr.
Izdano: (2021-12-01)

Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells.
od: Xia, Z, i dr.
Izdano: (2005)

The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization
od: Tina Gorsek Sparovec, i dr.
Izdano: (2022-04-01)

Cell-fate decision of mesenchymal stem cells toward osteocyte differentiation is committed by spheroid culture
od: Jeonghyun Kim, i dr.
Izdano: (2021-06-01)

Prolonged osteogenesis from human mesenchymal stem cells implanted in immunodeficient mice by using coralline hydroxyapatite incorporating rhBMP2 microspheres.
od: Fu, K, i dr.
Izdano: (2010)

Mitochondrial Dynamics: Fission and Fusion in Fate Determination of Mesenchymal Stem Cells
od: Lin Ren, i dr.
Izdano: (2020-10-01)

Comparative study between coralline hydroxyapatite and coverslips culture with mesenchymal stem cells
od: fu, K, i dr.
Izdano: (2007)

Building a consensus regarding the nature and origin of mesenchymal stem cells
od: Triffitt, J
Izdano: (2002)

Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate
od: Cristina Sobacchi, i dr.
Izdano: (2017-05-01)

The LINC complex, mechanotransduction, and mesenchymal stem cell function and fate
od: Tasneem Bouzid, i dr.
Izdano: (2019-08-01)

LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate
od: Jonathan A. R. Gordon, i dr.
Izdano: (2023-11-01)

The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate
od: Hamze Timari, i dr.
Izdano: (2017-12-01)

¬Mesenchymal Stem Cell Fate: Applying Biomaterials for Control of Stem Cell Behaviour
od: Hilary Jane Anderson, i dr.
Izdano: (2016-05-01)

Paving the way to a neural fate – RNA signatures in naive and trans-differentiating mesenchymal stem cells
od: Caroline Diener, i dr.
Izdano: (2024-12-01)

Zinc Promotes Adipose-Derived Mesenchymal Stem Cell Proliferation and Differentiation towards a Neuronal Fate
od: Mi-Young Moon, i dr.
Izdano: (2018-01-01)

Transplanting rejuvenated blood stem cells extends lifespan of aged immunocompromised mice
od: Sara Montserrat-Vazquez, i dr.
Izdano: (2022-12-01)

The regulatory effect of hyaluronan on human mesenchymal stem cells’ fate modulates their interaction with cancer cells in vitro
od: Christian Vogeley, i dr.
Izdano: (2021-10-01)

PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate
od: Jiao Chen, i dr.
Izdano: (2021-01-01)

Epigenetic Regulation of Methylation in Determining the Fate of Dental Mesenchymal Stem Cells
od: Hui Zhang, i dr.
Izdano: (2022-01-01)

The circadian clock has roles in mesenchymal stem cell fate decision
od: Wenzhen Gao, i dr.
Izdano: (2022-05-01)

REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells.
od: Dilli Ram Bhandari, i dr.
Izdano: (2010-05-01)

Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate.
od: Justin R Tse, i dr.
Izdano: (2011-01-01)

Dental pulp stem cells retain mesenchymal phenotype despite differentiation toward retinal neuronal fate in vitro
od: Aishwarya Balasankar, i dr.
Izdano: (2022-10-01)

Myocardin-related transcription factor A (MRTFA) regulates the fate of bone marrow mesenchymal stem cells and its absence in mice leads to osteopenia
od: Hejiao Bian, i dr.
Izdano: (2016-10-01)

LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
od: Yuan Zhu, i dr.
Izdano: (2020-03-01)

Osteogenic differentiation of human mesenchymal stem cells on electroactive substrates
od: M.N. Tamaño-Machiavello, i dr.
Izdano: (2024-04-01)

Hypoxia-Inducible Non-coding RNAs in Mesenchymal Stem Cell Fate and Regeneration
od: Yu Ye, i dr.
Izdano: (2021-12-01)

Mechanically-sensitive miRNAs bias human mesenchymal stem cell fate via mTOR signalling
od: Jessica E. Frith, i dr.
Izdano: (2018-01-01)

Ca2+-activated mitochondrial biogenesis and functions improve stem cell fate in Rg3-treated human mesenchymal stem cells
od: Taeui Hong, i dr.
Izdano: (2020-11-01)